Results 1 to 10 of about 70,027 (183)

When annual screening is lost in long-term hydroxychloroquine users: Three illustrative cases [PDF]

open access: yesAmerican Journal of Ophthalmology Case Reports
Purpose: To illustrate the clinical consequences of prolonged loss to follow-up for annual screening in long-term hydroxychloroquine users through representative cases of hydroxychloroquine retinopathy.
Moonsu Kim, Seong Joon Ahn
doaj   +2 more sources

Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019 [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2021
Background/Aims The efficacies of lopinavir-ritonavir or hydroxychloroquine remain to be determined in patients with coronavirus disease 2019 (COVID-19).
Ji-Won Kim   +6 more
doaj   +1 more source

Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy.

open access: yesPLoS ONE, 2021
BackgroundHydroxychloroquine is not efficacious as post-exposure prophylaxis against coronavirus disease 2019 (COVID-19). It is not known whether as pre-exposure prophylaxis it may prevent COVID-19.ObjectiveTo compare the incidence of COVID-19 in Spanish
Juan Macías   +11 more
doaj   +1 more source

New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre [PDF]

open access: yesRevista Brasileira de Ginecologia e Obstetrícia, 2020
Objective: To determine pregnancy outcomes in women with systemic lupus erythematosus (SLE) who were treated with hydroxychloroquine in a tertiary center.
Rahana Abd Rahman   +5 more
doaj   +1 more source

Hydroxychloroquine-induced Retinal Toxicity

open access: yesFrontiers in Pharmacology, 2023
Long-term use of hydroxychloroquine can cause retinopathy, which may result in severe and progressive visual loss. In the past decade, hydroxychloroquine use has markedly increased and modern retinal imaging techniques have enabled the detection of early,
Imran H. Yusuf   +2 more
doaj   +1 more source

The mechanism of chloroquine/hydroxychloroquine and its application in stomatological diseases

open access: yes口腔疾病防治, 2021
Chloroquine and hydroxychloroquine are both classic 4-aminoquinoline antimalarial drugs with similar chemical structures and mechanisms of action.
LIN Lin, WU Kaihui, WANG Wenmei
doaj   +1 more source

Hyperpigmentation Induced by Hydroxychloroquine: A Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2019
Hydroxychloroquine is an antimalarial drug which is widely used in the treatment of rheumatoid arthritis, owing to its immunosuppressive and anti-inflammatory properties.
Bhanukumar Muthaiah   +2 more
doaj   +1 more source

Unmet needs and future perspectives in hydroxychloroquine retinopathy

open access: yesFrontiers in Medicine, 2023
Retinopathy is a well-recognized toxic effect of hydroxychloroquine treatment. As hydroxychloroquine retinopathy is potentially a vision-threatening condition, early detection is imperative to minimize vision loss due to drug toxicity.
Imran H. Yusuf   +2 more
doaj   +1 more source

Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study

open access: yesBMC Infectious Diseases, 2021
Background Hydroxychloroquine has not been associated with improved survival among hospitalized COVID-19 patients in the majority of observational studies and similarly was not identified as an effective prophylaxis following exposure in a prospective ...
Andrew Ip   +24 more
doaj   +1 more source

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019

open access: yesAnnals of Medicine, 2021
Hydroxychloroquine, initially used as an antimalarial, is used as an immunomodulatory and anti-inflammatory agent for the management of autoimmune and rheumatic diseases such as systemic lupus erythematosus.
Pankaj Bansal   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy